Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased dose Kaletra in HIV patients with viremia
NCT00414284Phase 4Terminated
- Sponsor
- Community Research Initiative of New England
- Start
- Jun 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Community Research Initiative of New England. Started Jun 2006; status: terminated.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00414284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414284.